John La Montagne dies

Leader in vaccine development at NIAID was 61

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

John R. La Montagne, who helped direct infectious disease research and vaccine development at the National Institute of Allergy and Infectious Diseases (NIAID) for nearly 30 years, died suddenly of a pulmonary embolism in Mexico City on November 2. He was 61.

La Montagne was a gifted leader and prescient thinker concerned with emerging infectious disease and global public health long before either became "fashionable," NIAID Director Anthony Fauci told The Scientist. Fauci chose La Montagne as his deputy in 1998, a post he held at the time of his death.

Trained as a microbiologist, La Montagne helped steer the US public health apparatus through some of its most turbulent times, orchestrating the development and licensing of a safer pertussis vaccine, leading NIAID's response to the emerging AIDS crisis, and organizing a research response to severe acute respiratory syndrome within months of the first outbreak. He played key roles in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Anne Harding

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours